FDA warning letter
Closeout letter
Issue date
5 Nov 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
12 Nov 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Issue date
1 Aug 2023
Issue date
Issuing office
Posted date
Subject
Products & Services
Issue date
Issue date
Issuing office
Posted date
Subject
Products & Services
Issue date